Chemotherapy-Associated Extracellular Vesicles Modulate T Cells Activity and Cytokine Release

Nur Syahada  Ab Razak; Nadiah  Abu

doi:10.30683/1929-2279.2024.13.10

Chemotherapy-Associated Extracellular Vesicles Modulate T Cells Activity and Cytokine Release

Authors

Nur Syahada Ab Razak UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, 56000 Kuala Lumpur, Malaysia
Nadiah Abu UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, 56000 Kuala Lumpur, Malaysia

DOI:

https://doi.org/10.30683/1929-2279.2024.13.10

Keywords:

Exosomes, lymphocytes, FOLFOX, colorectal cancer

Abstract

Colorectal cancer (CRC) remains one of the most widely diagnosed cancers worldwide. Despite the advances in medical research, there is still a lot to be explored between cancer cells and the tumor microenvironment, namely immune cells. Extracellular vesicles (EVs) have been shown to mediate communication between cells and can modulate the activity of immune cells. External stimuli such as stress and chemotherapy can influence the activity of the released EVs. Nevertheless, the relationship between chemotherapy, EVs and immune cells has yet to be fully explored. In this study, we aimed to elucidate the immune-related functional mechanisms of EVs isolated from pre- and post- FOLFOX chemotherapy from CRC patients. The EVs were isolated from the serum of matched patients and characterized via dynamic light scattering. The EVs were then co-incubated with primary CD8 T cells isolated from healthy donors and Jurkat cells. The apoptosis, cell cycle profile, gene expression and cytokines were evaluated. Upon treatment with EVs, the T cells underwent apoptosis however no differences were seen in the cell cycle phases. Gene expression related to cytokine release was also differentially expressed namely IRF4. The level of cytokines that were released also differed between the two groups. Our study has shown that there are some minor differences in the activity of the EVs after induction with chemotherapy.

References

Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin 2023; 73(3): 233-54. https://doi.org/10.3322/caac.21772 DOI: https://doi.org/10.3322/caac.21772

Muhamad NA, Ma'amor NH, Rosli IA, Leman FN, Abdul Mutalip MH, Chan HK, et al. Colorectal cancer survival among Malaysia population: data from the Malaysian National Cancer Registry. Front Oncol 2023; 13: 1132417. https://doi.org/10.3389/fonc.2023.1132417 DOI: https://doi.org/10.3389/fonc.2023.1132417

Lissoni P, Fumagalli L, Brivio F, Rovelli F, Messina G, Di Fede G, et al. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology. Journal of Biological Regulators and Homeostatic Agents 2006; 20(1-2): 29-35.

Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. The Journal of Clinical Investigation 2016; 126(4): 1139-43. https://doi.org/10.1172/JCI87316 DOI: https://doi.org/10.1172/JCI87316

Yasodha K, Lizha Mary L, Surajit P, Satish R. Exosomes from metastatic colon cancer cells drive the proliferation and migration of primary colon cancer through increased expression of cancer stem cell markers CD133 and DCLK1. Tissue and Cell 2023; 84: 102163. https://doi.org/10.1016/j.tice.2023.102163 DOI: https://doi.org/10.1016/j.tice.2023.102163

Chimote AA, Lehn MA, Bhati J, Mascia AE, Sertorio M, Lamba MA, et al. Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma. Cancers (Basel) 2024; 16(5). https://doi.org/10.3390/cancers16051008 DOI: https://doi.org/10.3390/cancers16051008

Rausch L, Flaskamp L, Ashokkumar A, Trefzer A, Ried C, Buchholz VR, et al. Phosphatidylserine-positive extracellular vesicles boost effector CD8+ T cell responses during viral infection. Proceedings of the National Academy of Sciences 2023; 120(16): e2210047120. https://doi.org/10.1073/pnas.2210047120 DOI: https://doi.org/10.1073/pnas.2210047120

Abu N, Othman N, Ab Razak NS, Bakarurraini N, Nasir SN, Soh JEC, et al. Extracellular Vesicles Derived From Colorectal Cancer Affects CD8 T Cells: An Analysis Based on Body Mass Index. Front Cell Dev Biol 2020; 8: 564648. https://doi.org/10.3389/fcell.2020.564648 DOI: https://doi.org/10.3389/fcell.2020.564648

Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles 2024; 13(2): e12404. https://doi.org/10.1002/jev2.12451 DOI: https://doi.org/10.1002/jev2.12451

Ludwig S, Floros T, Theodoraki MN, Hong CS, Jackson EK, Lang S, et al. Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 2017; 23(16): 4843-54. https://doi.org/10.1158/1078-0432.CCR-16-2819 DOI: https://doi.org/10.1158/1078-0432.CCR-16-2819

Mondal SK, Haas D, Han J, Whiteside TL. Small EV in plasma of triple negative breast cancer patients induce intrinsic apoptosis in activated T cells. Communications Biology 2023; 6(1): 815. https://doi.org/10.1038/s42003-023-05169-3 DOI: https://doi.org/10.1038/s42003-023-05169-3

Hirsch T, Neyens D, Duhamel C, Bayard A, Vanhaver C, Luyckx M, et al. IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression. Cell Reports 2024; 43(7). https://doi.org/10.1016/j.celrep.2024.114401 DOI: https://doi.org/10.1016/j.celrep.2024.114401

Yan H, Dai Y, Zhang X, Zhang H, Xiao X, Fu J, et al. The transcription factor IRF4 determines the anti-tumor immunity of CD8(+) T cells. iScience 2023; 26(11): 108087. https://doi.org/10.1016/j.isci.2023.108087 DOI: https://doi.org/10.1016/j.isci.2023.108087

Vulpis E, Cecere F, Molfetta R, Soriani A, Fionda C, Peruzzi G, et al. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis. OncoImmunology 2017; 6(3): e1279372. https://doi.org/10.1080/2162402X.2017.1279372 DOI: https://doi.org/10.1080/2162402X.2017.1279372

Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. Frontiers in Immunology 2018; 9. https://doi.org/10.3389/fimmu.2018.00847 DOI: https://doi.org/10.3389/fimmu.2018.00847